Volume 11.5
Rapid Publication of Manuscript and Pre-prints on
Coronavirus disease (COVID-19) in the Western Pacific Region

As of 29 January 2020, more than 6000 cases of COVID-19 have been confirmed, and over 130 people have died. So far, the majority of COVID-19 cases have occurred in the Western Pacific Region, predominantly China, and cases continue to be detected in the region and globally.

To support public health responders with information to act quickly, WPSAR invites articles on public health surveillance and response in the context of the Coronavirus disease (COVID-19) in the Western Pacific Region. 

Examples of articles include, but are not limited to:

  • Findings, analysis and interpretation of COVID-19 surveillance data
  • Reports of outbreak investigations and risk assessments
  • Case report and case management report related to COVID-19
  • Description or evaluations of laboratory methodologies
  • Findings and lessons from infection prevention and public health measures aimed at reducing transmission of COVID-19
  • Innovative approaches and new technologies
  • Perspectives or lessons learnt on any issue to do with COVID-19

Authors should note the following changes to WPSAR submission in the context of the COVID-19 outbreak:

  • Articles submitted for COVID-19 will enter WPSAR’s rapid publication process. This will mean rapid review and publication within 2 weeks of submission.
  • WPSAR will accept manuscripts as “preprints” to be posted online within 2 days of submission.
    • Submissions will undergo basic quality screening (see below) before posting online.
    • Submissions will be noted as pre-prints until formal review and publication is completed.

Links and resources

To submit your manuscript or pre-print:
Information for authors:
WPRO COVID-19 home: (
WHO COVID-19 home: (

Manuscript and Preprint Screening

All manuscript pre-prints posted by WPSAR will undergo basic screening to exclude non-scientific, unethical and offensive content, as well any material that might pose a health risk. Only manuscripts related to COVID-19 will be included. WPSAR reserves the right to decline to post any preprint for any reason.

Preprint manuscripts will be clearly marked and tagged as COVID-19 pre-publication. This data will be available for broad public use, under the terms of the Creative Commons Attribution IGO License. 

Manuscripts will at the same time be peer reviewed and a decision made on acceptance and publication in WPSAR journal.